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while up-regulating all other genes, suggesting a possible pro-
tective effect. Caspase-3, a key signaling molecule in apoptosis,
was signiﬁcantly up-regulated (12x FS) under Co alone. While
previous studies showed increased apoptosis due to mechanical
injury, we have now shown a direct link between chondrocyte
apoptosis in normal cartilage due to co-culture with excised joint
capsule.
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MICRORNA ARE DIFFERENTIALLY EXPRESSED IN
OSTEOARTHRITIC TISSUE
S.W. Jones, G.L. Watkins, S.M. Brockbank, M.R. Needham,
P. Newham
AstraZeneca, Macclesﬁeld, United Kingdom
Purpose: MicroRNA (miRNA) are short, non-coding RNA
molecules, endogenously produced in mammalian cells and are
believed to mediate protein translation. At present, around 300
human miRNA have been identiﬁed with each miRNA hypo-
thetically targeting the translation of multiple genes. Previous
studies have demonstrated both differential tissue biodistribu-
tion and disease-speciﬁc expression of miRNA suggesting that
miRNA regulate important physiological and pathological pro-
cesses. However, currently little research has been undertaken
to identify miRNA associated with osteoarthritis (OA) or to deter-
mine the role of miRNA in the progression of this disease.
Methods: To investigate the role of miRNA in OA we proﬁled
the expression of 157 human miRNA (Applied biosystems early
access panel) in human cartilage and bone tissue from both
normal (control) donors and OA donors. MiRNA were extracted
from cartilage and bone tissue using Trizol and the miRNA
expression quantiﬁed by 2-step Taqman PCR utilising RT stem
loop primers (Applied Biosystems) for ﬁrst strand synthesis, and
normalised to 18S.
Results: In total, 28 miRNA were identiﬁed with differential
expression between diseased and normal cartilage tissue. The
most notable changes were miR-9, miR-25 and miR-98, which
were upregulated by 8-, 8- and 23-fold respectively, and miR-107,
miR-146 and miR-149, which were downregulated by 4-, 4-, and
27, fold respectively. Furthermore, in bone miR-27b, miR34c and
miR-122a were upregulated by 5-, 21- and 9-fold respectively
Conclusions: Our results show that miRNA are differentially
expressed in both OA cartilage and OA bone. Modulating the ex-
pression and/or activity of these differentially expressed miRNA
may help to understand the role of these miRNA in OA and could
lead to identifying novel targets for therapeutic intervention.
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Purpose: Chondrocytes utilize glucose both for energy produc-
tion and plastic functions, including the synthesis of matrix com-
ponents. Increasing evidence suggests that alterations in am-
bient glucose concentrations outside of normoglycemic ranges,
as occurs in poorly controlled diabetes mellitus, can signiﬁcantly
impair chondrocyte anabolic functions. This is in agreement with
recent studies showing a correlation between metabolic dysfunc-
tion, nutrient imbalance, diabetes mellitus and OA. Glucose up-
take and delivery to metabolic and synthetic pools is, thus, crucial
for chondrocyte functions. This work aimed at elucidating whether
alterations in the extracellular glucose concentration affect its
transport into chondrocytes, namely by elucidating the effects of
those alterations on the expression of the glucose transporter-1
(GLUT-1) and on the overall glucose uptake capacity.
Methods: Human chondrocytes were isolated from the cartilage
of the femoral condyles of cadaveric tissue donors without macro-
scopic signs of osteoarthritis. Subconﬂuent chondrocyte cultures
were set up and serum starved for 16 hours after an initial 24h
recovery period in medium supplemented with 5% FBS. Then,
the cells were incubated in media containing different glucose
concentrations (0, 5, 10 and 30 mM D-glucose) in the pres-
ence or absence of 4µM diphenyliodonium chloride (a NADPH
oxidase inhibitor), for 48 hours. In another set of experiments
and to further characterize the role of reactive oxygen species
(ROS) on GLUT-1 expression, the chondrocyte cultures in regu-
lar medium (10 mM glucose) were treated with H2O2, 100µM or
IL-1β, 30ng/ml. Total GLUT-1 content in whole cell lysates was
evaluated by Western blot. Glucose uptake was measured as
the amount of non-metabolizable 2-Deoxy-D-2-[2,6-3H]glucose
transported into chondrocytes for 30 minutes at 37°C.
Results: Glucose deprivation for 48 hours signiﬁcantly increased
total GLUT-1 protein levels (129,5±3,4%) and 2-Deoxy-D-
Glucose uptake (114,2±5%) relatively to cells cultured with either
5 or 10 mM glucose. In contrast, GLUT-1 content (79,1±9,1%)
and 2-Deoxy-D-Glucose uptake (72,3±3%) decreased in cells
cultured for 48 hours under high glucose concentrations (30
mM). Furthermore, for each glucose concentration tested, ad-
dition of diphenyliodonium chloride further increased GLUT-1
protein levels. Further emphasizing the role of reactive oxygen
species, treatment of chondrocyte cultures under normal glucose
concentration with H2O2 reduced GLUT-1 content to 75,8±2,1%,
an effect similar to that observed with 30mM glucose. On the
opposite, IL-1β increased GLUT-1 protein levels to 164±4,1% of
those found in cells cultured under normal glucose conditions
(10 mM).
Conclusions: Chondrocytes are capable of regulating GLUT-
1 expression and the rate of glucose transport in response to
alterations in the extracellular glucose concentration. Both GLUT-
1 protein levels and glucose uptake are upregulated in response
to glucose deprivation, what can maximize the ability of the cell
to capture as much glucose as possible. The opposite occurs as
the available glucose augments, which may constitute a defense
mechanism against deleterious effects of increased intracellular
glucose levels such as production of glucose-derived ROS. This
is in agreement with the effects observed with H2O2 and with
the antioxidant diphenyliodonium chloride, indicating that ROS
mediate high glucose-induced downregulation of GLUT-1 levels
and glucose uptake.
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Purpose: In Osteoarthritis the matrix metalloproteinases (MMPs)
are important for collagen degradation and are suspects in the
development of this disease. Especially MMP- 13 is present
in cartilage and thought to be one of the major collagen
proteinases.BMP-2 (bone morphogenic protein 2) is an impor-
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tant player in chondrocyte growth and differentiation. Regulation
by methylation which is the most common DNA modiﬁcation
remains unknown for arthrotic cartilage.
The aim of this study was to evaluate the inﬂuence of demethy-
lation on the gene expression of MMP - 13, BMP-2, Fli-1, Aggre-
cane, BMP-4 and collagen X.
Methods: We collected eight probes of human cartilage before
undergoing total knee joint replacement under sterile conditions
from osteoarthritis patients (5 female, 3 male). The average
patient’s age was 70 years (min 54, max 83). After digestion, the
cells were spread out and half of them were treated with 10 uM
of demethylation agent 5-AZA-deoxy-cytidine over a period of six
days. After harvesting the cells, RNA was extracted using the
Trizol method and cDNA was transcribed. Gene expression for
MMP-13, BMP-2, BMP-4, Aggrecane, Fli-1 and collagen X was
performed with the Taqman Realtime PCR Assay.
Results: Interestingly there was a remakable increase (4-fold)
of the gene expression of MMP-13 and a 1, 5-fold increase
of BMP-2 gene expression after treatment with 5-Aza-deoxy-
cytidine in the human arthrotic cartilage cell cultures compared
to the untreated controls. There was no obvious change in gene
expression for BMP-4, collagen X, Fli-1 and Aggrecane.
Conclusions: Further investigations are needed to show if
methylation plays a major role in regulating this pro-arthrotic
enzyme. If so this may lead us to new therapeutic aspects of
Osteoarthritis in the future.
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Purpose: Osteoarthritis (OA) is a joint disease characterized by
a degenerative change of articular cartilage and underlying sub-
chondral bone and often accompanied by inﬂammation. MSM,
a dietary supplement composed of about 34% sulfur and self-
afﬁrmed as GRAS (generally recognized as safe) in the U.S.,
is most utilized for treating osteoarthritis. A recent study by Kim
et. al., OA & Cart, 2006, showed clinical effectiveness of MSM
supplementation at 3 gm BID x 12 weeks compared to placebo.
The objective of our study was to examine the effect of MSM
at varying concentrations on cultured human healthy and os-
teoarthritic chondrocytes in vitro with a focus on catabolic and
anabolic markers.
Methods: Human cartilage tissues were obtained from 22 knees,
72 hrs postmortem from donors with different grades of OA. We
used the Outerbridge classiﬁcation (Grades I - IV), Grade I for
intact surface; Grade II for minimal ﬁbrillation; Grade III for overt
ﬁbrillation; and Grade IV for erosion of the articular cartilage
surface. Following gross assessment of the donor knees, the
following knees were studied for Grade I (n=6) (aged 23-38);
Grade II (n=9) (aged 50-77); for Grade III (n=5) (aged 32-70);
and Grade IV (n=2) (aged 70-93). Cartilage tissues were har-
vested from femoral condyles and tibial plateaus, the matrix was
dissolved with collagenase; the chondrocytes were then cultured
for 2 weeks in culture media without MSM. After reaching con-
ﬂuence, the chondrocytes were harvested and 2 x 105 cells in
10 ml culture medium with varying concentrations of MSM (0, 1,
3, 6, 12, and 60 µg/ml) were cultured in 100 mm (in-diameter)
plates at 37°C in 5% CO2 for 3 days. The concentrations were
estimated to correspond to human, oral dosing at between 0
and 30 grams of MSM per day. mRNA expression of various
markers by RT-PCR including: TNF-alpha, IL-1, MMP-1, MMP-3,
and MMP-13 was also determined for each OA grade and each
concentration of MSM or control. Anabolic pathways examined
included proteoglycan synthesis (by a pulse chase analysis of
35SO4 incorporation) and chondrocyte mRNA expressions of
Type-II collagen and aggrecan. A one-way ANOVA was per-
formed to establish the level of statistical signiﬁcance.
Results: In Grade II OA chondrocytes treated with MSM at the
concentration of 12 µg/ml, there was a strong trend for MSM
to reduce the mRNA expression of inﬂammatory markers: TNF-
alpha (-33%, p=0.08) and IL-1 (-29%, p=0.08) when compared to
lower concentrations of MSM and control. These results did not
apply for OA chondrocytes of Grade III or IV. MSM did not show
an increase in proteoglycan synthesis in cultured chondrocytes
or an increase of cartilage matrix production in normal and
osteoarthritic chondrocytes at the mRNA level.
Conclusions: MSM might have an ability to protect articular
cartilage in early OA by reducing expression of inﬂammatory cy-
tokines, i.e. TNF-alpha & IL-1. The effective concentration of 12
µg/ml MSM correlates with the dosage used in a recent clinical
trial. MSM did not elicit an anabolic response in this study.
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Purpose: Joint bleeds occur as a result of joint trauma or major
joint surgery. These joint bleeds, or haemarthroses, have a direct
devastating effect on the matrix turnover of articular cartilage,
which is due to apoptosis of the chondrocytes, as we have pre-
viously shown. Also the synovium is affected by the joint bleeds.
The synovium clears the blood from the joint, which leads to
haemosiderin deposition and successive synovial inﬂammatory
activities. This adds to the cartilage damage via the production
of pro-inﬂammatory - and tissue destructive mediators.
Recently we showed that relatively low concentrations of blood
present for a short period of time already lead to long-lasting
damage of human articular cartilage when determined in vitro.
The present study was undertaken to determine whether in vivo
these negative effects occur as rapid as determined in vitro.
Methods: Autologous blood was injected into the knee joint of
Beagle dogs, either 48 hours, 24 hours or 15 minutes before
termination. The amount of red and white blood cells present in
the joint cavity at the time of termination were determined. The
proteoglycan synthesis rate and release of the cartilage were
determined. Furthermore the cartilage destructive properties of
the synovial tissue were tested by measuring the proteoglycan
synthesis rate, -release and -content of healthy cartilage after
exposure to culture supernatants of synovial tissue from the
blood-exposed joints. All results were compared to the values of
the uninjected joint.
Results: Fifteen minutes after the injection of autologous blood,
the red blood cell count was 67*1012/L, comparable to the amount
present in whole blood, and gradually decreased (50% at 24
hours) to 6,7*1012/L within 48 hours (<10%). The amount of
white blood cells increased in the ﬁrst 24 hours, and was still
increased after 48 hours, although less than after 24 hours.
The proteoglycan synthesis rate and -release were adversely
affected already within 24 hours (-15% and +23% respectively),
and these effects were more severe 48 hours post-injection
(-31% and +32% resp.). Synovial tissue culture supernatants
